These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6120200)

  • 1. [Studies on a method for the assay of antibody to Bordetella pertussis fimbrial hemagglutinin after inoculation with pertussis HA vaccine (author's transl)].
    Murase Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):511-23. PubMed ID: 6120200
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities.
    Halperin SA; Barreto L; Eastwood BJ; Law B; Roberts EA
    Arch Pediatr Adolesc Med; 1994 Nov; 148(11):1220-4. PubMed ID: 7921131
    [No Abstract]   [Full Text] [Related]  

  • 4. An antigen-conserving ELISA for detecting human antibodies to Bordetella pertussis filamentous hemagglutinin.
    Vernon SK; Wiener FP; Urbano C; Levner MH
    J Biol Stand; 1986 Apr; 14(2):157-61. PubMed ID: 2876000
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Jul; 25(1):460-2. PubMed ID: 39033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
    Storsaeter J; Hallander HO; Gustafsson L; Olin P
    Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis fimbriae (Fim): relevance for vaccines.
    Gorringe AR; Vaughan TE
    Expert Rev Vaccines; 2014 Oct; 13(10):1205-14. PubMed ID: 25102891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen.
    Granström M; Granström G; Lindfors A; Askelöf P
    J Infect Dis; 1982 Dec; 146(6):741-5. PubMed ID: 6128367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
    Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
    J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD; Gornbein J; Heininger U; Stehr K
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International collaborative study: evaluation of proposed International Reference Reagent of pertussis antiserum (mouse) 97/642.
    Gaines Das R; Xing D; Rigsby P; Newland P; Corbel M
    Biologicals; 2001 Jun; 29(2):137-48. PubMed ID: 11580218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of pertussis antibody in the infant and effect on vaccine response.
    Van Savage J; Decker MD; Edwards KM; Sell SH; Karzon DT
    J Infect Dis; 1990 Mar; 161(3):487-92. PubMed ID: 2313127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.
    Ashworth LA; Irons LI; Dowsett AB
    Infect Immun; 1982 Sep; 37(3):1278-81. PubMed ID: 6127315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the status of acellular pertussis vaccines in practice.
    Lopez AL; Blumberg DA
    Drugs; 1997 Aug; 54(2):189-96. PubMed ID: 9257078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Aug; 25(2):764-7. PubMed ID: 39897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to pertussis vaccines concurrently administered with viral vaccines.
    Halperin SA; Eastwood BJ; Langley JM
    Ann N Y Acad Sci; 1995 May; 754():89-96. PubMed ID: 7625684
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
    van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
    Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Bordetella pertussis agglutinogen 2 and fimbriae.
    Carter EJ; Preston NW
    J Med Microbiol; 1984 Aug; 18(1):87-94. PubMed ID: 6146723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.